Market closed
Calidi Biotherapeutics Inc./$CLDI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
Ticker
$CLDI
Sector
Trading on
AMEX
Industry
Biotechnology
Headquarters
Employees
28
Website
CLDI Metrics
BasicAdvanced
$18M
-
-$2.97
1.19
-
Price and volume
Market cap
$18M
Beta
1.19
52-week high
$0.95
52-week low
$0.35
Average daily volume
416K
Financial strength
Current ratio
1.077
Quick ratio
1.01
Long term debt to equity
131.606
Total debt to equity
357.52
Interest coverage (TTM)
-23.34%
Management effectiveness
Return on assets (TTM)
-112.47%
Return on equity (TTM)
708.76%
Valuation
Price to book
7.14
Price to tangible book (TTM)
7.14
Price to free cash flow (TTM)
-0.197
Growth
Earnings per share change (TTM)
-82.83%
3-year earnings per share growth (CAGR)
-18.70%
CLDI News
AllArticlesVideos
Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement
GlobeNewsWire·2 weeks ago
Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement
GlobeNewsWire·3 weeks ago
Calidi Biotherapeutics Announces Demonstrated Ability To Deliver Transient Gene Therapy (Payload) To Tumors Using Systemic Platform
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Calidi Biotherapeutics Inc. stock?
Calidi Biotherapeutics Inc. (CLDI) has a market cap of $18M as of April 17, 2025.
What is the P/E ratio for Calidi Biotherapeutics Inc. stock?
The price to earnings (P/E) ratio for Calidi Biotherapeutics Inc. (CLDI) stock is 0 as of April 17, 2025.
Does Calidi Biotherapeutics Inc. stock pay dividends?
No, Calidi Biotherapeutics Inc. (CLDI) stock does not pay dividends to its shareholders as of April 17, 2025.
When is the next Calidi Biotherapeutics Inc. dividend payment date?
Calidi Biotherapeutics Inc. (CLDI) stock does not pay dividends to its shareholders.
What is the beta indicator for Calidi Biotherapeutics Inc.?
Calidi Biotherapeutics Inc. (CLDI) has a beta rating of 1.19. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.